XML 20 R6.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Cash flows from operating activities:    
Net (loss) income $ (10,440,000) $ 17,770,000
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation and amortization of property, plant and equipment 6,078,000 4,896,000
Amortization of intangible assets with finite lives 7,348,000 4,682,000
Amortization of stock-based compensation 3,166,000 3,642,000
Amortization of deferred financing costs 292,000 65,000
(Gain) loss on disposal of property, plant and equipment (15,000) 3,000
Provision for allowance for doubtful accounts 670,000 315,000
Provision for excess and obsolete inventory 2,022,000 1,962,000
Excess income tax benefit from stock-based award exercises (23,000) (140,000)
Deferred income tax benefit (516,000) (1,103,000)
Changes in assets and liabilities, net of effects of business acquisition:    
Accounts receivable 23,057,000 (13,049,000)
Inventories 5,068,000 (8,729,000)
Prepaid expenses and other current assets 1,877,000 (225,000)
Other assets (306,000) (40,000)
Accounts payable (9,846,000) (3,882,000)
Accrued expenses and other current liabilities (4,013,000) (3,152,000)
Customer advances and deposits (5,910,000) 5,063,000
Other liabilities, non-current (882,000) (608,000)
Interest payable 82,000 (29,000)
Income taxes payable (5,436,000) 242,000
Net cash provided by operating activities 12,273,000 7,683,000
Cash flows from investing activities:    
Payments for business acquisition, net of cash acquired (280,535,000) 0
Purchases of property, plant and equipment (3,063,000) (2,833,000)
Net cash used in investing activities (283,598,000) (2,833,000)
Cash flows from financing activities:    
Borrowings of debt 351,905,000 0
Required payments for debt assumed for business acquisition (134,101,000) 0
Cash dividends paid (14,540,000) (14,581,000)
Payment of deferred financing costs (10,123,000) 0
Repayment of long-term debt including capital lease obligations (3,842,000) 0
Payment of shelf registration costs (337,000) 0
Repurchases of common stock 0 (4,989,000)
Proceeds from exercises of stock options 0 1,417,000
Proceeds from issuance of employee stock purchase plan shares 499,000 707,000
Excess income tax benefit from stock-based award exercises 23,000 140,000
Net cash provided by (used in) financing activities 189,484,000 (17,306,000)
Net decrease in cash and cash equivalents (81,841,000) (12,456,000)
Cash and cash equivalents at beginning of period 150,953,000 154,500,000
Cash and cash equivalents at end of period 69,112,000 142,044,000
Cash paid during the period for:    
Interest 2,976,000 117,000
Income taxes 4,766,000 8,970,000
Non-cash investing and financing activities:    
Accrued fixed asset additions 125,000 0
Cash dividends declared but unpaid (including accrual of dividend equivalents) 5,265,000 5,115,000
Accrued deferred financing costs 139,000 0
Accrued shelf registration costs $ 20,000 $ 0